Cheville JC (2026). [PMID: 41173324](https://pubmed.ncbi.nlm.nih.gov/41173324/). *Mod Pathol*. [Basic Science / Preclinical]
Alshoabi SA (2026). [PMID: 42198662](https://pubmed.ncbi.nlm.nih.gov/42198662/). *Pathogens*. [Review / Meta-Analysis]
Akbulut D (2026). [PMID: 41384692](https://pubmed.ncbi.nlm.nih.gov/41384692/). *Histopathology*. [Review / Meta-Analysis]
Corbin H (2026). [PMID: 42003828](https://pubmed.ncbi.nlm.nih.gov/42003828/). *Cytopathology*. [Epidemiology / Natural History]
Harrs CF (2026). [PMID: 41384686](https://pubmed.ncbi.nlm.nih.gov/41384686/). *Histopathology*. [Review / Meta-Analysis]
Simon N (2025). [PMID: 40116623](https://pubmed.ncbi.nlm.nih.gov/40116623/). *Future Oncol*. [Clinical Trial Publication]
Xu D (2025). [PMID: 40893664](https://pubmed.ncbi.nlm.nih.gov/40893664/). *Cancer Heterog Plast*. [Basic Science / Preclinical]
Chu J (2025). [PMID: 41323974](https://pubmed.ncbi.nlm.nih.gov/41323974/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Bellmunt J (2025). [PMID: 40467365](https://pubmed.ncbi.nlm.nih.gov/40467365/). *Eur Urol*. [Clinical Trial Publication]
Wang JS (2025). [PMID: 39928161](https://pubmed.ncbi.nlm.nih.gov/39928161/). *J Cancer Res Clin Oncol*. [Case Report / Case Series]
